Cyclo Therapeutics Stock Price, News & Analysis
Company Description
Cyclo Therapeutics (NASDAQ: CYTHW) is a publicly traded drug manufacturers - specialty & generic company in the Biological Products, (no Disgnostic Substances) sector.
CYTHW stock has declined 89.0% over the past year. Shares last traded at $0.0320.
This page provides a comprehensive overview of CYTHW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cyclo Therapeutics (CYTHW) stock last traded at $0.0320. Over the past 12 months, the stock has lost 89.0%.
Latest News
Cyclo Therapeutics has 4 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. Key topics include offering. View all CYTHW news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CYTHW Company Profile & Sector Positioning
Cyclo Therapeutics (CYTHW) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.
Investors comparing CYTHW often look at related companies in the same sector, including Biofrontera (BFRIW), Clever Leaves Holdings Inc (CLVRW), Sunshine Biopharma Inc (SBFMW), Scynexis (SCYX), and APIMEDS PHARMACEUTICALS US INC (APUS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CYTHW's relative position within its industry.